论文部分内容阅读
陈旧性深静脉血栓的治疗相当棘手。本组针对此类病人血液纤维蛋白原明显增高,血流动力学长期处于高凝、高粘状态试行东菱精纯克栓酶为主药,辅以克拉瑞定的新治疗方案。对18例病人的治疗和3月～6月的随访观察,全部有效。4例随访中有症状复发,但较治疗前轻。复发病例可再次治疗。2例再次治疗期间作了血管转流手术,切口和皮下均无异常渗血。
The treatment of old deep venous thrombosis is quite tricky. The group for such patients was significantly higher blood fibrinogen, hemodynamic long-term hypercoagulability, high-viscosity state trial Dongling Jing Ke acylicase-based drugs, combined with the new treatment of clariding. The treatment of 18 patients and 3 months to 6 months follow-up observation, all effective. Symptoms were recurred in 4 cases, but were lighter than those before treatment. Recurrent cases can be treated again. Vascular bypass surgery was performed in 2 cases during the second treatment, and there was no abnormal bleeding in the incision or subcutaneous.